Sarah is currently the head of the Developmental and Reproductive Toxicology (DART) group in Drug Safety Research and Development at Pfizer. She received her PhD in pharmacology and toxicology from the University of Connecticut in 2008. Prior to joining Pfizer in 2010, she was a postdoctoral fellow at Brown University where she studied male reproductive toxicology. As a member of the DART group at Pfizer, Sarah is involved in the design and interpretation of both regulatory and investigative DART studies in addition to providing nonclinical support for pediatric indications and expertise for nonclinical labeling contributions related to pregnancy and fertility.